Clinical Trials Browser

Lymphoma, Non-Hodgkin, Recurrence, Lymphoma, Large B-Cell, Diffuse

Recurrence, Triple Negative Breast Neoplasms

Hodgkin Disease, Recurrence

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Recurrence, Lymphoma, Large B-Cell, Diffuse

Head and Neck Neoplasms, Recurrence

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Neoplasm Metastasis, Recurrence

Recurrence, Lymphoma, Large B-Cell, Diffuse

Nasopharyngeal Carcinoma, Recurrence

Recurrence, Lymphoma, Large-Cell, Anaplastic

Recurrence, Leukemia, Myeloid, Acute

Recurrence, Lymphoma, Large B-Cell, Diffuse

Glioblastoma, Recurrence

Leukemia, Lymphoma, Recurrence, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Extranodal Extension, Recurrence, Lymphoma, Large B-Cell, Diffuse

Central Nervous System Diseases, Recurrence, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Recurrence, Leukemia, Myeloid, Acute

Recurrence, Hematologic Neoplasms

Recurrence, Lymphoma, Large B-Cell, Diffuse, Dendritic Cell Sarcoma, Interdigitating

Recurrence, Leukemia, Myeloid, Acute

Carcinoma, Ovarian Epithelial, Recurrence

Recurrence, Lymphoma, T-Cell, Peripheral

Lymphoma, Recurrence

Lymphoma, Follicular, Recurrence

Carcinoma, Hepatocellular, Recurrence

Hodgkin Disease, Recurrence

Recurrence, Lymphoma, B-Cell

Lymphoma, Recurrence

Lymphoma, Non-Hodgkin, Recurrence

Recurrence, Lymphoma, B-Cell

Nasopharyngeal Carcinoma, Recurrence

Uterine Cervical Neoplasms, Recurrence

Hodgkin Disease, Recurrence

Recurrence, Lymphoma, T-Cell, Peripheral

Recurrence, Lymphoma, Large B-Cell, Diffuse

Graft vs Host Disease, Recurrence, Neoplasm, Residual

Recurrence, Small Cell Lung Carcinoma

Esophageal Squamous Cell Carcinoma, Neoplasm Metastasis, Recurrence

Recurrence, Lymphoma, Mantle-Cell

Head and Neck Neoplasms, Recurrence

Recurrence, Lymphoma, Large B-Cell, Diffuse

Neoplasms, Recurrence, Lymphoma, Large B-Cell, Diffuse

Lymphoma, Non-Hodgkin, Recurrence

Hodgkin Disease, Recurrence

Neoplasm Metastasis, Recurrence

Recurrence, Lymphoma, Extranodal NK-T-Cell

Graft vs Host Disease, Recurrence

Multiple Myeloma, Recurrence, Disease Progression

Nasopharyngeal Carcinoma, Recurrence

Clinical Trials

CD19-targeted CAR T Cells for Relapsed and Refractory (R/R) Large B-cell Lymphoma

BELLA

Prolgo-HL

CD19-targeted CAR T Cells for Relapsed and Refractory (R/R) Non-Hodgkins Lymphoma

Safety and Superiority of Penicillamine in Radiosensitization of Recurrent Head and Neck Cancer

V-CHANCE

Study of BEBT-908 in the Relapsed or Refractory Diffuse Large B-cell Lymphoma Subjects

Tranilast as a Radiosensitizer in Reradiation of Nasopharyngeal Carcinoma

CRU3

Study of Selinexor Combined With Chidamide in Relapsed/Refractory Acute Leukemia (AML) Patients

Prospective Clinical Study of ZPR Regimen in Relapsed/Refractory Diffuse Large B-cell Lymphoma

TaRRGET

Venetoclax Plus IM2 Regimen for Relapsed and Refractory T Lymphoblastic Lymphoma/Leukemia

Decitabine and Anti-PD-1 in R/R DLBCL

CILI

Phase 2, Open-Label, Single Arm Study, With BST-236 in Adults With R/R AML or Higher-Risk MDS

Azacitidine in Combination With Venetoclax Treatment for MRD Positive Post Allo-HSCT AML/MDS Patients

Relyage

AARON

BOLD

A Single-arm, Multicenter, Prospective Clinical Study of Mitoxantrone Liposome Combined With Chidamide and Azacitidine in the Treatment of Relapsed and Refractory Peripheral T-cell Lymphoma

Camrelizumab Combined With CD30 CAR-T in the Treatment of Relapsed/Refractory CD30+ Lymphoma

Orelabrutinib Plus Rituximab Followed by Maintenance With Orelabrutinib for Relapsed and Refractory Follicular Lymphoma(RR FL)

A Study to Evaluate TACE Sequential Tislelizumab as Adjuvant Therapy in Participants With HCC at High Risk of Recurrence After Curative Resection

PD-1 Inhibitor Combined With Decitabine Followed by ASCT as Second-line Therapy for Relapsed or Refractory Classic Hodgkin's Lymphoma

SHR1459 in Combination With YY-20394 in Recurrent and Refractory B-cell Non-Hodgkin's Lymphoma

MITO29

Ibrutinib Combined With Rituximab for Treatment of Relapsed Refractory MYD88 and CD79A/B (or CD79B Alone) DLBCL Who Have Received at Least Two Prior Therapies

A Study of CD19/22 CART Cells Combined With PD-1 Inhibitor in Relapsed/Refractory B-cell Lymphoma

Study of Chidamide as a Single-agent Treatment for Patients With Relapse or Refractory B-NHL

Endostar for Locally Recurrent Nasopharyngeal Carcinoma

A Study of TQB2450 Injection in Subjects With PD-L1 Positive Recurrent or Metastatic Cervical Cancer

BASALT

Chidamide Combination With Lenalidomide in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma

Chidamide Combined With VDDT Regimen in the Relapse and Refractory Diffuse Large B Cell Lymphoma

Chemotherapy and DLI for Prevention of Second Relapse in Patients With Relapsed Acute Leukemia After Allotransplant

Irinotecan Plus Lobaplatin Versus Irinotecan in the Second-line Treatment of Small Cell Lung Cancer

Apatinib in the Treatment of Recurrence or Metastasis of Esophageal Cancer

MAN2

RePASS

LEGEND

Study of Ibrutinib in Combination With Bendamustine and Rituximab for Patients With Relapsed/Refractory Aggressive BCL

CAR-T for R/R B-NHL

SHR-1210 Alone or in Combination With Decitabine in Relapsed or Refractory Hodgkin Lymphoma

MICADO

A Trial to Evaluate the Efficacy of Poziotinib, Pan HER Inhibitor in Recurrent/Metastatic Esophageal Cancer (R/M ESCC)

A Study of Liposome-entrapped Mitoxantrone Hydrochloride Injection in Relapsed/Refractory Peripheral T-cell Lymphoma and NK/T-cell Lymphoma

Prophylactic Donor Lymphocyte Infusion After Allo-PBSCT for Patients With Very High-risk Hematologic Malignancies

MM-POM-2018

Nimotuzumab for Recurrent Nasopharyngeal Carcinoma